Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Stockholders Equity of $3.16 billion for fiscal year 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.16B | -8.6% |
| 2024 | $3.46B | -3.8% |
| 2023 | $3.60B | +20.9% |
| 2022 | $2.98B | +17.4% |
| 2021 | $2.53B | +19.9% |
| 2020 | $2.11B | +29.4% |
| 2019 | $1.63B | +24.1% |
| 2018 | $1.32B | +26.1% |
| 2017 | $1.05B | +24.9% |
| 2016 | $836.77M | +14.1% |
| 2015 | $733.07M | +9.1% |
| 2014 | $672.20M | +4.9% |
| 2013 | $640.98M | +6.7% |
| 2012 | $600.80M | +14.3% |
| 2011 | $525.58M | -23.5% |
| 2010 | $687.42M | -50.0% |
| 2009 | $1.38B | +10.8% |
| 2008 | $1.24B | -35.0% |
| 2007 | $1.91B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.41B | -10.0% | +1.6% |
| June 30, 2025 | $3.35B | -9.9% | +5.0% |
| March 31, 2025 | $3.19B | -12.3% | -7.7% |
| December 31, 2024 | $3.46B | -3.8% | -8.5% |
| September 30, 2024 | $3.78B | +14.4% | +1.6% |
| June 30, 2024 | $3.72B | +14.5% | +2.3% |
| March 31, 2024 | $3.64B | +17.1% | +1.2% |
| December 31, 2023 | $3.60B | +20.9% | +8.8% |
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -8.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s stockholders equity has grown by 65.8% (from $1.91 billion to $3.16 billion).
- The most recent figure is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: